You are here

  • Home
  • Archive
  • Volume 76, Issue 1
  • A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study

Article metrics

Article menu
Download PDFPDF
Clinical and epidemiological research
Extended report
A phase III, multicentre, randomised, double-blind, active-controlled, parallel-group trial comparing safety and efficacy of HD203, with innovator etanercept, in combination with methotrexate, in patients with rheumatoid arthritis: the HERA study

 

Online download statistics by month:

Online download statistics by month: February 2016 to April 2023

AbstractFullPdf
Feb 20165343590
Mar 201642298104
Apr 20161613430
May 2016912721
Jun 20161352824
Jul 2016802916
Aug 20161452528
Sep 2016881518
Oct 20161132310
Nov 2016832819
Dec 2016146936155
Jan 20179882290
Feb 20172583730
Mar 20171724851
Apr 20171602812
May 2017924225
Jun 20171313126
Jul 20172302920
Aug 20171832617
Sep 20171522120
Oct 20171371611
Nov 20171722623
Dec 2017140119
Jan 20182042723
Feb 2018158199
Mar 20181631710
Apr 2018176227
May 2018210156
Jun 20181971712
Jul 2018156157
Aug 201818484
Sep 20181812012
Oct 20181222211
Nov 201811741
Dec 201811695
Jan 201912775
Feb 2019103147
Mar 201910161
Apr 201988108
May 20199497
Jun 20196988
Jul 201981148
Aug 201912073
Sep 201965137
Oct 2019121175
Nov 2019107124
Dec 201998133
Jan 2020164136
Feb 202073113
Mar 2020118101
Apr 20204161
May 20209035
Jun 20208332
Jul 20208183
Aug 20205432
Sep 20206520
Oct 202085174
Nov 20204351
Dec 20209972
Jan 20215386
Feb 20214774
Mar 202156107
Apr 20215978
May 20214363
Jun 2021871
Jul 2021663
Aug 202112113
Sep 2021960
Oct 202174131
Nov 20218951
Dec 20219790
Jan 20224723
Feb 20224710
Mar 20228594
Apr 20226780
May 202213521
Jun 20228271
Jul 20228270
Aug 202210882
Sep 202213490
Oct 2022112133
Nov 20224942
Dec 202211264
Jan 202390123
Feb 202312562
Mar 202354141
Apr 20233173
Total1220313381118